rockie - A few things....
1. I think it depends on how many people actually read/visit "Life Sciences Review Magazine/website" and/or how many people it reaches.
2. Being ranked #1 in antibodies, the plandemic19 nasal spray, etc... is all great & very, very exciting. However, nothing concrete/definitive has actually been announced yet, so it's just talk at this point.
3. INTL continues dumping on us. We don't know if they're selling existing shares or diluting. If they are diluting, the pps will not move up anywhere near as fast, especially since INTL is/has been for the past 3+ days, responsible for 90% of the volume.
That said, what was disclosed in the article is extremely exciting and great news, but I believe we'll need something definitive/concrete to bring in the volume needed to climb towards an accurate valuation. Especially while we're still dealing with INTL/OTCN.